Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies (Q37152291)
Jump to navigation
Jump to search
scientific article published on May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies |
scientific article published on May 2008 |
Statements
1 reference
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies (English)
1 reference
Gianluigi Ferretti
1 reference
Giulio Metro
1 reference
Alessandra Fabi
1 reference
Paola Papaldo
1 reference
Marcella Mottolese
1 reference
Paolo Carlini
1 reference
Alessandra Felici
1 reference
Michelangelo Russillo
1 reference
Francesco Cognetti
1 reference
Identifiers
1 reference